Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 7/22/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Ingmar Hoerr

Wrong Dr. Ingmar Hoerr?

Chief Executive Officer

Local Address: Tübingen, Germany
Company Description: CureVac is an integrated biopharmaceutical company with a pipeline of promising drug candidates. Using its RNA technology platform, CureVac is currently developing...   more

Employment History


  • PhD , biology
    Tuebingen University
  • MBA
    Danube University
  • PhD , biology
    Tübingen University
  • PhD , biochemistry
    Tübingen University
  • MBA
    Danube University of Krems
63 Total References
Web References
"We are very pleased that our ..., 1 July 2014 [cached]
"We are very pleased that our RNActive technology platform has reached all significant milestones in this important collaboration with Sanofi Pasteur, the largest company entirely dedicated to vaccines," said Ingmar Hoerr, CEO of CureVac.
Ingmar Hoerr, PhD, ..., 4 Jan 2014 [cached]
Ingmar Hoerr, PhD, MBA Chief Executive Officer
Ingmar Hoerr received his PhD in biology from Tuebingen University, and an MBA from Danube University in Krems, Austria.
Florian worked with Biotest GmbH and Roche AG before joining CureVac in 2000 - working with Ingmar Hoerr to build the business from the start.
Ingmar Hoerr, Ph.D., chief ..., 16 Dec 2013 [cached]
Ingmar Hoerr, Ph.D., chief executive officer of CureVac, said, "We are proud to announce the on-time completion of patient recruitment in this clinical trial.
"The outstanding presentations at the 1st ..., 5 Nov 2013 [cached]
"The outstanding presentations at the 1st International mRNA Health Conference in Tuebingen demonstrated the tremendous medical potential of mRNA for many different diseases," said Ingmar Hoerr, chief executive officer and co-founder of CureVac, initiator of the conference.
"There has been a great amount ..., 4 Nov 2013 [cached]
"There has been a great amount of progress made in the cancer immunotherapy field recently, and we believe that checkpoint inhibitors could work even more efficiently with fewer side effects when combined with targeted anti-tumor guidance through an efficient vaccination approach such as RNActive®," said Ingmar Hoerr, Ph.D., chief executive officer at CureVac.
Other People with the name "Hoerr":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.